Literature DB >> 2641459

Assessment of hepatic excretory function in chronic liver disease by hepatobiliary scintigraphy.

H Itoh1, N Takahashi, R Shimono, T Sugawara, M Kawamura, T Tsuda, M Kataoka, A Iio, K Hamamoto, K Ohshima.   

Abstract

Hepatobiliary scintigraphy was performed in 23 normal subjects and 47 patients with chronic liver disease (chronic hepatitis; n = 27, liver cirrhosis; n = 20) to evaluate its availability as a test of liver function. After intravenous administration of Tc-99m N-pyridoxyl-5-methyl-tryptophan, the data were acquired for 60 min and the time-activity curves of ROIs (the heart and liver) were generated. In two compartment model simulation, the early blood clearance rate (kl), late blood clearance rate (km), hepatic uptake rate (ku) hepatic excretion rate (ke), and hepatic excretion T 1/2 were calculated. There was no significant difference in those four k values in normal and chronic hepatitis. However, in liver cirrhosis each of them, except km, was lower than in normal subjects. The kl value correlated closely with the indocyanine green plasma clearance test, whereas the ke and T 1/2 values were closely correlated with the level of serum bilirubins. Only hepatobiliary scintigraphy showed the excretory function of the liver quantitatively and the ke value was helpful in detecting hepatic excretory dysfunction early in chronic liver disease before serum bilirubins increased.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2641459     DOI: 10.1007/bf03178300

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  12 in total

1.  [Application of deconvolution analysis to Tc-99m-PMT hepatobiliary scintigraphy].

Authors:  J Gon; T Nakagawa; H Maeda; K Nakamura; T Tashiro; H Sakuma; N Kato; Y Matsuoka; T Hirano; N Yamaguchi
Journal:  Kaku Igaku       Date:  1987-09

2.  Evaluation of subjective assessment of liver function from radionuclide images.

Authors:  J R Jago; C J Gibson; B L Diffey
Journal:  Br J Radiol       Date:  1987-02       Impact factor: 3.039

3.  Detection, localization, and quantitation of degree of common bile duct obstruction by scintigraphy.

Authors:  G T Krishnamurthy; D A Lieberman; H S Brar
Journal:  J Nucl Med       Date:  1985-07       Impact factor: 10.057

4.  [Quantitative analysis by digital computer with Tc-99m PMT hepatogram in diffuse parenchymal liver diseases].

Authors:  I Narabayashi; N Ishido; K Sugimura; K Nabeshima; M Matsuo; S Kimura; A Kajita
Journal:  Kaku Igaku       Date:  1984-01

5.  [The quantitative evaluation of the dynamic functions of hepatobiliary system by using Tc-99m-pyridoxylideneisoleucine (author's transl)].

Authors:  K Yamamoto; H Ito; Y Morimoto; S Bito; N Oshiro; T Mori
Journal:  Kaku Igaku       Date:  1981-12

6.  Measurement of colloid clearance rate as an adjunct to static liver imaging.

Authors:  J Miller; B L Diffey; J S Fleming
Journal:  Eur J Nucl Med       Date:  1979-02-01

7.  Simple computer quantitation of spleen-to-liver ratios in the diagnosis of hepatocellular disease.

Authors:  R Wasnich; G Glober; T Hayashi; T Vicher; F Yeh
Journal:  J Nucl Med       Date:  1979-02       Impact factor: 10.057

8.  Technetium-99m BIDA biliary scintigraphy in the evaluation of the jaundiced patient.

Authors:  A W Lee; M D Ram; W J Shih; K Murphy
Journal:  J Nucl Med       Date:  1986-09       Impact factor: 10.057

9.  Sequential scintiphotography with technetium-99m pyridoxylideneglutamate in the detection of intrahepatic lithiasis: concise communication.

Authors:  S H Yeh; O K Liu; M J Huang
Journal:  J Nucl Med       Date:  1980-01       Impact factor: 10.057

10.  TC-99m(Sn)-N-pyridoxylaminates: a new series of hepatobiliary imaging agents.

Authors:  M Kato-Azuma
Journal:  J Nucl Med       Date:  1982-06       Impact factor: 10.057

View more
  1 in total

1.  Detection of complications after liver transplantation by technetium-99m mebrofenin hepatobiliary scintigraphy.

Authors:  T Mochizuki; W N Tauxe; J Dobkin; A N Shah; R Shanker; S Todo; T E Starzl
Journal:  Ann Nucl Med       Date:  1991-09       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.